What You Should Know
Swedish neurotechnology company Flow Neuroscience officially launched FL-100 across the United States, introducing the first FDA-approved at-home transcranial direct current stimulation (tDCS) treatment for depression to the American market.Backed by formal premarket approval
Read More
Flow Neuroscience Launches FDA-Approved At-Home tDCS Treatment for Major Depressive Disorder



























































